Skip to main content

Table 5 The development of non- alcoholic fatty liver disease across quartiles of energy-adjusted daily calcium to magnesium ratio intake

From: Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study

 

Energy-adjusted daily calcium to magnesium ratio intake

Q1(n = 250)

Q2(n = 249)

P-value*

Q3(n = 250)

P-value*

Q4(n = 250)

P-value*

Cases/control

27/223

34/215

 

49/201

 

86/164

 

Range of Ca to Mg ratio

0.95 to 1.97

1.97 to 2.36

 

2.36 to 2.81

 

2.82 to 5.02

 

aModel 1

1 (Ref)

1.30

(0.76–2.23)

0.33

2.01

(1.21–3.34)

0.007

4.33

(2.68–6.97)

< 0.001

bModel 2

1 (Ref)

1.22

(0.71–2.11)

0.46

1.93

(1.15–3.21)

0.012

4.45

(2.75–7.21)

< 0.001

cModel 3

1 (Ref)

1.57

(0.73–3.35)

0.24

2.89

(1.35–6.16)

0.006

5.72

(2.82–11.60)

< 0.001

dModel 4

1 (Ref)

1.82

(0.76–4.37)

0.17

2.86

(1.20–6.81)

0.017

5.97

(2.54–14.01)

< 0.001

  1. Data are presented as odds ratio (95 %CI)
  2. *Logistic regression
  3. acrude model
  4. bAdjusted for age and gender
  5. cAdditionally adjusted for body mass index, alcohol consumption, smoking, diabetes and physical activity
  6. dAdditionally adjusted for energy, dietary fiber, carbohydrate, fat, and protein intakes
  7. The significance level: P < 0.05